APA (7th ed.) Citation

A, R., LF, L., M, C., D, M., M, M., M, M., . . . A, R. (2017). Impact of universal access to hepatitis C therapy on HIV-infected patients: Implementation of the Spanish national hepatitis C strategy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 36(3), 487. https://doi.org/10.1007/s10096-016-2822-6

Chicago Style (17th ed.) Citation

A, Rivero-Juarez, et al. "Impact of Universal Access to Hepatitis C Therapy on HIV-infected Patients: Implementation of the Spanish National Hepatitis C Strategy." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 36, no. 3 (2017): 487. https://doi.org/10.1007/s10096-016-2822-6.

MLA (9th ed.) Citation

A, Rivero-Juarez, et al. "Impact of Universal Access to Hepatitis C Therapy on HIV-infected Patients: Implementation of the Spanish National Hepatitis C Strategy." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, vol. 36, no. 3, 2017, p. 487, https://doi.org/10.1007/s10096-016-2822-6.